METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF LIVER-RELATED COMPLICATIONS: A NATIONWIDE COHORT STUDY

被引：0
|
作者：
Shin, Hyunjae [1 ]
Park, Min Kyung [2 ]
Moon, Hye-Sung [3 ]
Chung, Sung Won [4 ]
Ko, Yunmi [2 ]
Park, Youngsu [2 ]
Park, Jeayeon [2 ]
Hur, Moon Haeng [1 ]
Bin Lee, Yun [1 ]
Cho, Eun Ju [2 ]
Lee, Jeong-Hoon [2 ]
Yu, Su Jong [2 ]
Yoon, Jung-Hwan [2 ]
Kim, Yoon Jun [5 ,6 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
[3] Rexsoft, Seoul, South Korea
[4] Asan Med Ctr, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2225-A
引用
收藏
页码：S1012 / S1013
页数：2
相关论文
共 50 条
  • [41] Risk scores for metabolic dysfunction-associated fatty liver disease in pediatric obesity
    Lischka, Julia
    Lieb, Katharina
    Schanzer, Andrea
    Hojreh, Azadeh
    Ba-Ssalamah, Ahmed
    de Gier, Charlotte
    Walleczek, Nina-Katharina
    Zeyda, Maximilian
    Greber-Platzer, Susanne
    ANNALS OF NUTRITION AND METABOLISM, 2022, 78 (05) : 247 - 254
  • [42] Risk Factors for the Development of Metabolic Dysfunction-Associated Fatty Liver Disease in Mexico
    Tellez, S.
    Lopez, G.
    Gonzalez, M.
    Contreras, R.
    ANNALS OF NUTRITION AND METABOLISM, 2024, 80 : 138 - 139
  • [43] Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers
    Liu, Zhenqiu
    Lin, Chunqing
    Suo, Chen
    Zhao, Renjia
    Jin, Li
    Zhang, Tiejun
    Chen, Xingdong
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 127
  • [44] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (10) : 2182 - 2189
  • [45] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [46] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [47] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [48] Increased risk of cancers in metabolic dysfunction-associated steatotic liver disease and MetALD
    Park, Yewan
    Jung, Jooyi
    Kim, Gi-Ae
    JOURNAL OF HEPATOLOGY, 2024, 80 : S468 - S468
  • [49] Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study
    Cho, So Hyun
    Kim, Seohyun
    Oh, Rosa
    Kim, Ji Yoon
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Gyuri
    Kim, Jae Hyeon
    HEPATOLOGY INTERNATIONAL, 2024, 18 (04) : 1168 - 1177
  • [50] Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study
    Jeon, Yeong Jeong
    Han, Kyungdo
    Lee, Seung Woo
    Lee, Ji Eun
    Park, Junhee
    Cho, In Young
    Cho, Jong Ho
    Shin, Dong Wook
    DISEASES OF THE ESOPHAGUS, 2024, 37 (08)
12345